Wasabi leaf extracts attenuate adipocyte hypertrophy through PPARγ and AMPK

Area of Science:

• Metabolic Syndrome Research
• Nutritional Biochemistry
• Pharmacology

Background:

• Obesity-induced adipocyte hypertrophy disrupts adipocytokine signaling, leading to metabolic abnormalities like type 2 diabetes, hypertension, and dyslipidemia.
• Metabolic syndrome is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes.

Purpose of the Study:

• To investigate the efficacy of wasabi (Wasabia japonica Matsum) leaf extracts (WLE) in ameliorating metabolic abnormalities in a rat model of metabolic syndrome.
• To elucidate the molecular mechanisms underlying WLE's effects on adipose tissue and metabolic parameters.

Main Methods:

• Male SHRSP/ZF rats (a metabolic syndrome model) were treated orally with 4 g/kg/day of WLE or water for 6 weeks.
• Key metabolic parameters including body weight gain, blood pressure, plasma triglyceride levels, and adipose tissue characteristics were assessed.
• Gene expression analysis focused on PPARγ and related downstream targets, as well as adiponectin and AMPK activity.

Main Results:

• WLE treatment significantly improved body weight gain and reduced high blood pressure in the rats.
• Plasma triglyceride levels were markedly lower in the WLE-treated group compared to controls.
• Adipocyte hypertrophy was significantly prevented, accompanied by suppressed expression of PPARγ and its downstream genes in adipose tissue.
• WLE administration led to increased adiponectin levels and stimulated AMPK activity.

Conclusions:

• Wasabi leaf extract demonstrates significant potential in mitigating key features of metabolic syndrome in a preclinical model.
• WLE exerts its beneficial effects by inhibiting adipocyte hypertrophy, partly through the suppression of PPARγ expression and enhancement of adiponectin-mediated AMPK activation.